title: Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.
authors.forename: C
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmoll
authors.forename: M A
authors.initials: MA
authors.lastname: Kuczyk
authors.forename: J
authors.initials: J
authors.lastname: Beyer
authors.forename: W
authors.initials: W
authors.lastname: Siegert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D013736:Testicular Neoplasms / Q000188:drug therapy*
chemical_list: D005047:Etoposide